SpringWorks Therapeutics (SWTX) News Today $46.75 +0.01 (+0.02%) Closing price 04:00 PM EasternExtended Trading$46.84 +0.09 (+0.18%) As of 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SWTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period SpringWorks Therapeutics (NASDAQ:SWTX) Sees Large Volume Increase - What's Next?SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading Volume - What's Next?June 9 at 12:46 PM | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Squarepoint Ops LLCSquarepoint Ops LLC cut its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 59.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,864 shares of the company's stock after selling 17,245 shares during the quarter.June 5, 2025 | marketbeat.comRFG Advisory LLC Takes $3.93 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)RFG Advisory LLC acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 88,995 shares of the company's stock, valued at approximately $3,June 4, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 19,315 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 19.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owneJune 4, 2025 | marketbeat.comSPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc. - SWTXJune 3, 2025 | businesswire.comNuveen Asset Management LLC Has $6.64 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Nuveen Asset Management LLC trimmed its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 38.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 183,761 shares of the company's stock after selling 114,138May 31, 2025 | marketbeat.comBNP Paribas Financial Markets Makes New $351,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)BNP Paribas Financial Markets acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 9,719 shares of the company's sMay 28, 2025 | marketbeat.comSpringWorks Therapeutics (SWTX) Surged on Acquisition NewsMay 27, 2025 | msn.comSpringWorks Therapeutics’ SWOT analysis: biotech stock faces acquisition challengesMay 27, 2025 | investing.comProShare Advisors LLC Has $827,000 Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)ProShare Advisors LLC boosted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 31.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,883 shares of the company's stock aftMay 26, 2025 | marketbeat.comDeutsche Bank AG Increases Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Deutsche Bank AG increased its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 47.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 60,714 shares of the company's stock after acquiring an additiMay 25, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Consensus Recommendation of "Hold" from AnalystsSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) has earned a consensus rating of "Hold" from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and one has given a buy rating tMay 25, 2025 | marketbeat.comPalisades Investment Partners LLC Buys 12,154 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Palisades Investment Partners LLC grew its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 9.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 134,445 shares of the company's sMay 24, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Bank of America Corp DEBank of America Corp DE cut its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 51.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 416,888 shares of the company's stock aMay 24, 2025 | marketbeat.comSpringWorks gets EU endorsement for genetic disorder treatmentMay 23, 2025 | msn.comSpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PNMay 23, 2025 | globenewswire.comWoodline Partners LP Buys 108,512 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Woodline Partners LP increased its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 7.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,490,136 shares of the company'sMay 22, 2025 | marketbeat.comZimmer Partners LP Buys New Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Zimmer Partners LP bought a new stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 142,300 shares of the company's stock, valued at apprMay 22, 2025 | marketbeat.comVelan Capital Investment Management LP Makes New $6.70 Million Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Velan Capital Investment Management LP bought a new stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 185,520 shares of the company's sMay 21, 2025 | marketbeat.comRafferty Asset Management LLC Has $4.44 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Rafferty Asset Management LLC lessened its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 11.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 122,943 shares of the company's stock after seMay 21, 2025 | marketbeat.com30,811 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Tema Etfs LLCTema Etfs LLC acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 30,811 shares of the company's stock, valued aMay 20, 2025 | marketbeat.comEnsign Peak Advisors Inc Lowers Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ensign Peak Advisors Inc trimmed its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 88.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 19,041 shares of the company's stock after selling 145,903 shares during the period. EnsigMay 19, 2025 | marketbeat.comSphera Funds Management LTD. Makes New $3.61 Million Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Sphera Funds Management LTD. purchased a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 100,000 shares of the compMay 18, 2025 | marketbeat.comPatient Square Capital LP Invests $3.37 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Patient Square Capital LP purchased a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 93,137 shares of the companMay 16, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by D. E. Shaw & Co. Inc.D. E. Shaw & Co. Inc. cut its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 46.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 387,733 shares of the company's stock after selling 336,949 shares during tMay 16, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Orbimed Advisors LLCOrbimed Advisors LLC lessened its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 9.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,255,031 shares of the company's sMay 15, 2025 | marketbeat.comAmeriprise Financial Inc. Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ameriprise Financial Inc. lifted its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 21.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 971,099 sharMay 15, 2025 | marketbeat.comNorthern Trust Corp Acquires 52,908 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Northern Trust Corp grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 8.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 655,678 shares of the company's stock after purMay 15, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Given "Neutral" Rating at GuggenheimGuggenheim restated a "neutral" rating and issued a $47.00 price objective on shares of SpringWorks Therapeutics in a report on Monday.May 14, 2025 | marketbeat.comIntegral Health Asset Management LLC Purchases Shares of 100,000 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Integral Health Asset Management LLC purchased a new stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the company's stock, vMay 14, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by J. Goldman & Co LPJ. Goldman & Co LP cut its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 15.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 53,503 shares of the company's stock afteMay 14, 2025 | marketbeat.comBalyasny Asset Management L.P. Invests $3.10 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Balyasny Asset Management L.P. acquired a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 85,761 shares of the compMay 14, 2025 | marketbeat.comAlgert Global LLC Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Algert Global LLC bought a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 35,340 shares of the company's stock, valued at approximately $1,27May 12, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) is Deep Track Capital LP's 6th Largest PositionDeep Track Capital LP trimmed its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 10.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,460,756 shares of the company's stock after selling 383,144 shares durinMay 9, 2025 | marketbeat.comDuquesne Family Office LLC Acquires 154,628 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Duquesne Family Office LLC boosted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 21.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 859,694 shares of the company's stock after purchasinMay 9, 2025 | marketbeat.comDimensional Fund Advisors LP Lowers Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Dimensional Fund Advisors LP reduced its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 1.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 717,714 shares of the company's stoMay 9, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $14.73 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)The Manufacturers Life Insurance Company increased its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 42.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownedMay 6, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Acquires 7,072 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)ArrowMark Colorado Holdings LLC boosted its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 0.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,499,134 shares of the compaMay 5, 2025 | marketbeat.comAlly Bridge Group NY LLC Has $1.98 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ally Bridge Group NY LLC decreased its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 76.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 54,692 shares of the company's stock after selling 173,008 shaMay 4, 2025 | marketbeat.comBoxer Capital Management LLC Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Boxer Capital Management LLC bought a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 3,421,541 shares of the company's stock, valued at approximately $123,620,000. SprMay 4, 2025 | marketbeat.comSpringWorks Therapeutics' (SWTX) "Neutral" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "neutral" rating and set a $47.00 target price (down previously from $74.00) on shares of SpringWorks Therapeutics in a research note on Wednesday.May 2, 2025 | marketbeat.comEvercore ISI Downgrades SpringWorks Therapeutics (NASDAQ:SWTX) to HoldEvercore ISI downgraded SpringWorks Therapeutics from a "strong-buy" rating to a "hold" rating in a research note on Monday.May 2, 2025 | marketbeat.comPromising Growth Stocks To Follow Today - April 29thSpringWorks Therapeutics, Novo Nordisk A/S, Welltower, Apollo Global Management, Repligen, Blackstone, and BlackRock are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to expand their revenues and earnings at anMay 1, 2025 | marketbeat.comBiotech Stocks To Follow Now - April 29thSpringWorks Therapeutics, AbbVie, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any BioMay 1, 2025 | marketbeat.comSpringWorks Therapeutics' (SWTX) "Hold" Rating Reiterated at TD CowenTD Cowen reiterated a "hold" rating and set a $47.00 target price (down from $66.00) on shares of SpringWorks Therapeutics in a research report on Tuesday.May 1, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Stock Position Raised by Soros Fund Management LLCSoros Fund Management LLC lifted its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 7.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 600,470 shares of the company's stock after acquiring an additioMay 1, 2025 | marketbeat.comHC Wainwright & Co. Downgrades SpringWorks Therapeutics (SWTX)May 1, 2025 | msn.comPromising Value Stocks To Watch Now - April 28thSpringWorks Therapeutics, ProShares UltraPro Short QQQ, iShares Bitcoin Trust, Intel, and Berkshire Hathaway are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had tApril 30, 2025 | marketbeat.comTop Mid Cap Stocks Worth Watching - April 28thSpringWorks Therapeutics, ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Hims & Hers Health, and Pony AI are the five Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). ThesApril 30, 2025 | marketbeat.comBest Pharmaceutical Stocks To Watch Now - April 28thSpringWorks Therapeutics, Eli Lilly and Company, AbbVie, Pfizer, Merck & Co., Inc., Thermo Fisher Scientific, and Honeywell International are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (ToApril 30, 2025 | marketbeat.com Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SWTX Media Mentions By Week SWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTX News Sentiment▼1.701.01▲Average Medical News Sentiment SWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTX Articles This Week▼37▲SWTX Articles Average Week Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Intra-Cellular Therapies News Today Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Viatris News Today Qiagen News Today Blueprint Medicines News Today Roivant Sciences News Today Revolution Medicines News Today BridgeBio Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SWTX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SWTX Stock Free SWTX Stock Alerts